Related Experiment Video
Updated: Nov 29, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Genetic predisposition in pediatric oncology
Doina Paula Pruteanu1,2, Diana Elena Olteanu1, Rodica Cosnarovici1
1Department of Pediatric Oncology, "Prof. Dr. Ion Chiricuta" Oncology Institute, Cluj-Napoca, Romania.
Identifying genetic predisposition syndromes in pediatric oncology is crucial. Early recognition aids in timely diagnosis, treatment adjustments, and long-term monitoring for secondary cancers.
Area of Science:
- Oncology
- Genetics
- Pediatrics
Background:
- Genetic predisposition syndromes significantly impact cancer diagnosis and management.
- Germline mutations, inherited or de novo, are responsible for these syndromes.
- Understanding these genetic factors is vital for patient and family care.
Purpose of the Study:
- To review the most significant genetic syndromes associated with malignant pathology in pediatric oncology.
- To highlight the importance of identifying genetic predispositions for improved patient outcomes.
Main Methods:
- This review synthesizes current knowledge on genetic predisposition syndromes in pediatric oncology.
- It discusses various inheritance patterns including Mendelian and non-Mendelian mechanisms.
Main Results:
- Genetic predisposition can lead to earlier cancer diagnosis.
- Identifying these syndromes influences treatment plans, adverse effect monitoring, and surveillance for second neoplasms.
- Germline mutations are the underlying cause, with diverse inheritance patterns.
Conclusions:
- Recognizing genetic predisposition syndromes in pediatric cancer patients is essential for personalized care.
- This knowledge facilitates early detection, tailored treatment, and proactive surveillance strategies.
- A comprehensive understanding of genetic syndromes improves long-term management and patient prognosis.
Related Concept Videos
Cancer Prevention
Some...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

